Author:
Bartlett Edmund K.,Meise Chelsey,Bansal Neha,Fischer John P.,Low David W.,Czerniecki Brian J.,Roses Robert E.,Fraker Douglas L.,Kelz Rachel R.,Karakousis Giorgos C.
Reference33 articles.
1. Epidemiology of malignant melanoma;Desmond;Surg Clin North Am,2003
2. Howlader N NA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA SEER Cancer Statistics Review, 1975–2009 National Cancer Institute. Bethesda, MD 2011.
3. Trends in the treatment and survival for local and regional cutaneous melanoma in a US population-based study;Harlan;Melanoma Res,2011
4. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients;Gershenwald;J Clin Oncol,1999
5. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients;Karakousis;Ann Surg Oncol,2007
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献